摘要:
Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.
摘要:
Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting method and conventional antibody therapy and immunodiagnosis are provided.
摘要:
Radiolabeled annexin-galactors conjugates useful for imaging vascular trombi are discussed. Methods for making such radiolabeled annexin-galactose conjugates are also addressed.
摘要:
A therapeutic conjugate comprising a binding protein or peptide coupled to a therapeutic agent, wherein said binding protein or peptide specifically binds a target cell selected from at least one of vascular smooth muscle cells, tumor cells, stromal cells, interstitial matrix surrounding vascular smooth muscle cells or immune system effector cells, and wherein said therapeutic agent alters the cellular metabolism, or inhibits a cellular activity of the target cell.
摘要:
Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a cell surface of the vascular smooth muscle cell, coupled to a therapeutic agent that inhibits a cellular activity of the muscle cell.
摘要:
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin and for improved radiohalogenation of biotin, as well as related compounds, are described. Also, clearing agents, anti-ligand-targeting moiety conjugates, target cell retention enhancing moieties and additional methods are discussed.
摘要:
Liver retention clearing agents (LRCAs) and the use thereof are discussed. LRCAs are composed of a hepatic clearance directing component which directs the biodistribution of a LRCA-containing construct to hepatic clearance; a binding component which mediates binding of the LRCA to a compound for which rapid hepatic clearance is desired; a liver retention component which diminishes access of binding component-containing metabolites to target sites; and a structural component to provide a scaffold for the other components.
摘要:
Radiolabeled annexin-galactors conjugates useful for imaging vascular trombi are discussed. Methods for making such radiolabeled annexin-galactose conjugates are also addressed.